Logo image of RBRK

RUBRIK INC-A (RBRK) Stock Fundamental Analysis

NYSE:RBRK - New York Stock Exchange, Inc. - US7811541090 - Common Stock - Currency: USD

74.08  +3.21 (+4.53%)

After market: 74.1499 +0.07 (+0.09%)

Fundamental Rating

1

Taking everything into account, RBRK scores 1 out of 10 in our fundamental rating. RBRK was compared to 284 industry peers in the Software industry. RBRK has a bad profitability rating. Also its financial health evaluation is rather negative. RBRK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year RBRK has reported negative net income.
RBRK Yearly Net Income VS EBIT VS OCF VS FCFRBRK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 -100M -200M -300M

1.2 Ratios

With a Return On Assets value of -89.65%, RBRK is not doing good in the industry: 89.89% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -89.65%
ROE N/A
ROIC N/A
ROA(3y)-41.89%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RBRK Yearly ROA, ROE, ROICRBRK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 100 -100 200

1.3 Margins

RBRK's Gross Margin of 69.22% is in line compared to the rest of the industry. RBRK outperforms 53.43% of its industry peers.
The Profit Margin and Operating Margin are not available for RBRK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RBRK Yearly Profit, Operating, Gross MarginsRBRK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

1

2. Health

2.1 Basic Checks

RBRK does not have a ROIC to compare to the WACC, probably because it is not profitable.
RBRK has about the same amout of shares outstanding than it did 1 year ago.
RBRK has a worse debt/assets ratio than last year.
RBRK Yearly Shares OutstandingRBRK Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 50M 100M 150M
RBRK Yearly Total Debt VS Total AssetsRBRK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of -3.05, we must say that RBRK is in the distress zone and has some risk of bankruptcy.
RBRK has a Altman-Z score of -3.05. This is amonst the worse of the industry: RBRK underperforms 80.51% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.05
ROIC/WACCN/A
WACC10.85%
RBRK Yearly LT Debt VS Equity VS FCFRBRK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 200M -200M -400M -600M

2.3 Liquidity

RBRK has a Current Ratio of 1.16. This is a normal value and indicates that RBRK is financially healthy and should not expect problems in meeting its short term obligations.
RBRK has a Current ratio of 1.16. This is in the lower half of the industry: RBRK underperforms 67.87% of its industry peers.
A Quick Ratio of 1.15 indicates that RBRK should not have too much problems paying its short term obligations.
RBRK has a worse Quick ratio (1.15) than 67.51% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.15
RBRK Yearly Current Assets VS Current LiabilitesRBRK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

RBRK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -27.51%.
Looking at the last year, RBRK shows a small growth in Revenue. The Revenue has grown by 4.68% in the last year.
EPS 1Y (TTM)-27.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-45.01%
Revenue 1Y (TTM)4.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%42.62%

3.2 Future

RBRK is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.40% yearly.
RBRK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 31.26% yearly.
EPS Next Y7.12%
EPS Next 2Y16.43%
EPS Next 3Y18.4%
EPS Next 5YN/A
Revenue Next Year39.92%
Revenue Next 2Y34.03%
Revenue Next 3Y31.26%
Revenue Next 5YN/A

3.3 Evolution

RBRK Yearly Revenue VS EstimatesRBRK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 500M 1B
RBRK Yearly EPS VS EstimatesRBRK Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RBRK. In the last year negative earnings were reported.
Also next year RBRK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RBRK Price Earnings VS Forward Price EarningsRBRK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RBRK Per share dataRBRK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

A more expensive valuation may be justified as RBRK's earnings are expected to grow with 18.40% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.43%
EPS Next 3Y18.4%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RBRK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RUBRIK INC-A

NYSE:RBRK (2/4/2025, 8:04:09 PM)

After market: 74.1499 +0.07 (+0.09%)

74.08

+3.21 (+4.53%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)12-05 2024-12-05/amc
Earnings (Next)N/A N/A
Inst Owners56.58%
Inst Owner Change-0.64%
Ins Owners0.1%
Ins Owner Change4.67%
Market Cap6.45B
Analysts82.4
Price Target77.91 (5.17%)
Short Float %10.54%
Short Ratio3.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)34.2%
Min EPS beat(2)19.95%
Max EPS beat(2)48.45%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)4.43%
Min Revenue beat(2)2.41%
Max Revenue beat(2)6.45%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.05%
PT rev (3m)70.85%
EPS NQ rev (1m)5.03%
EPS NQ rev (3m)-3.13%
EPS NY rev (1m)0.71%
EPS NY rev (3m)12.03%
Revenue NQ rev (1m)3.48%
Revenue NQ rev (3m)5.86%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.15%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.03
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-6.4
EYN/A
EPS(NY)-1.3
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS9.22
BVpS-5.98
TBVpS-7.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -89.65%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 69.22%
FCFM N/A
ROA(3y)-41.89%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 1.15
Altman-Z -3.05
F-ScoreN/A
WACC10.85%
ROIC/WACCN/A
Cap/Depr(3y)110.5%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.31%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-45.01%
EPS Next Y7.12%
EPS Next 2Y16.43%
EPS Next 3Y18.4%
EPS Next 5YN/A
Revenue 1Y (TTM)4.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%42.62%
Revenue Next Year39.92%
Revenue Next 2Y34.03%
Revenue Next 3Y31.26%
Revenue Next 5YN/A
EBIT growth 1Y-17.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year24.03%
EBIT Next 3Y19.34%
EBIT Next 5YN/A
FCF growth 1Y-63.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-123.42%
OCF growth 3YN/A
OCF growth 5YN/A